The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Directorate change

14 Jul 2023 14:19

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Directorate change 14-Jul-2023 / 14:18 GMT/BST


 

Directorate Change

 

Jon Mortimore to be appointed to board of directors

 

ISE: DHG  LSE: DAL

 

Dublin and London | 14 July 2023: Dalata Hotel Group plc ("Dalata" or the "Group" or the "Company"), the largest hotel operator in Ireland with a growing presence in the United Kingdom and continental Europe, announces the appointment of a new independent non-executive director.

 

The board is pleased to announce that Jon Mortimore will join the board as an independent non-executive director on 1 August 2023.

Jon is an experienced CFO with over 30 years of experience in senior finance positions. He is the chief financial officer and an executive director of Dr. Martens plc. He previously served as chief financial officer of Avant Homes and Travelodge and was the Finance Director for WHSmith Retail and Hodder Headline. Jon is a graduate of the University of East Anglia and a member of the Chartered Institute of Management Accountants.

Jon will join the board's audit and risk and ESG committees upon appointment.

 

John Hennessy, Group Chair commented:

 

"I am delighted to welcome Jon to the Dalata board; he brings extensive executive experience across various consumer businesses in the UK and international markets, including in the hotel sector. His finance and capital markets expertise will complement the skills of the existing board members."

 

 

Committee Membership and director responsibilities effective from 1 August 2023

 

Audit and Risk

Remuneration

Nomination

ESG

Chair

Cathríona Hallahan

Elizabeth McMeikan1

John Hennessy

Gervaise Slowey2

Members

Elizabeth McMeikan

John Hennessy

Elizabeth McMeikan

Cathríona Hallahan

Jon Mortimore

Gervaise Slowey

Cathríona Hallahan

Jon Mortimore

 

 

 

Shane Casserly

1 Senior independent director

2 Designated non-executive director responsible for workforce engagement; audit and risk committee member (pro-tem) 27 April 2023 to 31 July 2023.

 

Additional disclosures pursuant to Euronext Dublin listing rule 6.1.66.

Mr Mortimore resigned from the board of Travelodge Hotels Limited (THL) on 28 March 2013, thus served as a director of THL within the 12 months preceding its agreed company voluntary arrangement in September 2013.

There is no other further information to be disclosed under listing rule 6.1.66.

 

-ENDS-

 

 

 

About Dalata

 

Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014. Dalata is Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group’s portfolio comprises 52 three and four-star hotels with 11,233 rooms and a pipeline of over 1,100 rooms. The Group currently has 31 owned hotels, 18 leased hotels and three management contracts. Dalata successfully operates Ireland’s two largest hotel brands, the Clayton and the Maldron Hotels. For the year ended 31 December 2022, Dalata reported revenue of €558.3 million and a profit after tax of €96.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com.

 

Contacts

 

 Dalata Hotel Group plc 

investorrelations@dalatahotelgroup.com

 Dermot Crowley, CEO

Tel +353 1 206 9400

Sean McKeon, Company Secretary and Head of Risk and Compliance

 

 Joint Group Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

 Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

 Melanie Farrell

dalata@fticonsulting.com

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:BOA
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:257921
EQS News ID:1680797
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
21st Apr 20207:00 amRNSSale & Leaseback of Clayton Charlemont Hotel
20th Apr 20201:05 pmRNSStatement re AGM
17th Apr 20203:01 pmRNSHolding(s) in Company
14th Apr 20209:12 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSHolding(s) in Company
1st Apr 20209:09 amRNSTotal Voting Rights
30th Mar 20205:33 pmRNSNotice of AGM
25th Mar 202012:00 pmRNSCovid-19 Update
23rd Mar 202011:00 amRNSHolding(s) in Company
20th Mar 20205:50 pmRNSDirector/PDMR Shareholding
20th Mar 20202:47 pmRNSDirector/PDMR Shareholding
19th Mar 20202:41 pmRNSDirector/PDMR Shareholding
18th Mar 202011:17 amRNSHolding(s) in Company
18th Mar 202010:45 amRNSHolding(s) in Company
18th Mar 202010:25 amRNSHolding(s) in Company
16th Mar 20204:41 pmRNSDirector/PDMR Shareholding
13th Mar 20205:17 pmRNSAnnual Financial Report
12th Mar 202012:21 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSEuronext Dublin Market Notice
10th Mar 20203:20 pmRNSHolding(s) in Company
10th Mar 20203:04 pmRNSHolding(s) in Company
9th Mar 202010:01 amRNSCOVID 19 Update
4th Mar 20209:40 amRNSStatement Block Listing Application
3rd Mar 20209:30 amRNSTotal Voting Rights
28th Feb 20203:10 pmRNSDirector/PDMR Shareholding
27th Feb 20203:52 pmRNSHolding(s) in Company
27th Feb 20209:39 amRNSHolding(s) in Company
25th Feb 20207:00 amRNSFull Year Results 2019
13th Feb 20209:52 amRNSHolding(s) in Company
13th Feb 20207:00 amRNSSigned a New Lease Agreement
5th Feb 20208:07 amRNSTotal Voting Rights
20th Jan 20204:29 pmRNSHolding(s) in Company
7th Jan 20202:59 pmRNSBlock listing Interim Review
7th Jan 20202:35 pmRNSNotice of Results
3rd Jan 202010:02 amRNSTotal Voting Rights
18th Dec 20197:00 amRNSTrading and Development Update
17th Dec 20197:00 amRNSDirector Appointment and Board Committee Changes
16th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:40 pmRNSHolding(s) in Company
4th Dec 20193:30 pmRNSDirector/PDMR Shareholding
3rd Dec 201910:12 amRNSTotal Voting Rights
28th Nov 20198:15 amRNSReplacement Holding(s) in Company
27th Nov 20193:55 pmRNSHolding(s) in Company
21st Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:09 pmRNSAcquisition
14th Nov 20199:07 amRNSDirector Declaration
5th Nov 20195:15 pmRNSHolding(s) in Company - Replacement
1st Nov 20199:45 amRNSTotal Voting Rights
24th Oct 20193:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.